UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition Cortimyk20mgml10mgmlkram-SE-PLC-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-100013279-00012627, http://ema.europa.eu/fhir/eurdId
/2052
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Cream
indication:
Tinea (dermatofytoser orsakade av Trichophyton-, Epidermophyton- och Microsporum-arter) och kutana candidiasis med inflammatoriskt inslag och/eller där klåda är besvärande.
legalStatusOfSupply: Medicinal product subject to medical prescription exempt for some pack sizes
classification: imidazoles/triazoles in combination with corticosteroids
name
productName: Cortimyk 20 mg/g + 10 mg/g kräm
part
part: Cortimyk
type: Invented name part
part
part: 20 mg/g + 10 mg/g
type: Strength part
part
part: kräm
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish